期刊文献+

人脐带间充质干细胞裂解液对食管癌EC9706细胞中尿激酶型纤溶酶原激活物和基质金属蛋白酶-2表达的影响

Effect of lysate from human umbilical cord mesenchymal stem cells on the expression of urokinase plasminogen activator and matrix metalloproteinases-2 in esophageal carcinoma EC9706 cells
下载PDF
导出
摘要 目的探讨人脐带间充质干细胞(h UCMSCs)裂解液对食管癌EC9706细胞中尿激酶型纤溶酶原激活物(u PA)及基质金属蛋白酶-2(MMP-2)表达的影响。方法收集h UCMSCs,采用反复冻融法制备h UCMSCs裂解液;不同浓度h UCMSCs裂解液作用于食管癌EC9706细胞60 h,对照组加入体积分数10%胎牛血清的培养液。采用Western blot法检测食管癌EC9706细胞中u PA、MMP-2的表达。结果加入h UCMSCs数<食管癌细胞数的裂解液时,食管癌EC9706细胞中u PA、MMP-2的表达与对照组比较差异无统计学意义(P>0.05);加入h UCMSCs数≥食管癌细胞数的裂解液时,食管癌EC9706细胞中u PA、MMP-2的表达较对照组显著降低(P<0.05)。结论 h UCMSCs裂解液对食管癌EC9706细胞的迁移抑制作用可能与u PA、MMP-2有关。 Objective To investigate the effect of the lysate from human umbilical cord mesenchymal stem cells( h UCMSCs) on the expression of urokinase plasminogen activator( u PA) and matrix metalloproteinases-2( MMP-2) in esophageal carcinoma EC9706 cells. Methods h UCMSCs were collected and cell lysate was prepared through repeated freeze-thaw cycles. EC9706 cells were treated by cell lysates with different cell numbers of h UCMSCs for 60 hours while the control group was treated with the 10% fetal bovine serum. The expression of u PA and MMP-2 in EC9706 was detected by Western blot. Results The lysate from h UCMSCs with numbers less than treated EC9706 cells did not change both u PA level and MMP-2 level in EC9706 cells when compared with control group( P 0. 05). The expression of u PA and MMP-2 in EC9706 cells was decreased significantly compared with control group when the lysate from h UCMSCs with the number of cell was equal or greater than treated EC9706 cells( P 0. 05). Conclusion h UCMSCs lysate can inhibit the migration of esophageal carcinoma EC9706 cells,which may be associated with u PA and MMP-2.
出处 《新乡医学院学报》 CAS 2015年第4期299-302,共4页 Journal of Xinxiang Medical University
基金 河南省基础与前沿技术研究计划项目(编号:112300410163)
关键词 人脐带间充质干细胞 食管癌 尿激酶型纤溶酶原激活物 基质金属蛋白酶-2 human umbilical cord mesenchymal stem cells esophageal carcinoma urokinase plasminogen activator matrix metalloproteinases-2
  • 相关文献

参考文献12

  • 1Xn Y, Yu X, Chen Q, et al. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcino- ma[J]. World J Surg 0ncol,2012,10:173.
  • 2Tran G D ,Sun X D ,Abnet C C ,et al. Prospective study of risk fac- tors for esophageal and gastric cancers in the Linxian general popula- tion trial cohort in China[J]. lnt J Cancer,2005,113(3) :456-463.
  • 3Enzinger P C, Mayer R ]. Esophageal cancer [ J ]. N Engl J Med, 2003,349 ( 23 ) : 2241-2252.
  • 4祝淑钗,王亚飞,沈文斌,李娟,苏景伟,王玉祥.食管癌中uPA、uPAR蛋白表达及其临床意义[J].肿瘤防治研究,2008,35(7):508-511. 被引量:3
  • 5Choong P F, Nadesapillai A P. Urokinase plasminogen activator sys- tem:a muhifunctional role in tumor progression and metastasis [ J ]. Clin Orthop Relat Res ,2003 (415 Suppl) : $46-$58.
  • 6叶晓锋,高平,韩恩善,等.MMP-2、VEGF、PTEN的表达与食管癌浸润转移的关系[J].宁夏医科大学学报,2012,34(4):326-329.
  • 7刘富磊,齐博,赵宝生,姚文建,李汉臣,白玉,钟根深.人脐带间充质干细胞裂解液在体外对食管癌EC9706细胞增殖与迁移的抑制作用[J].新乡医学院学报,2014,31(4):248-252. 被引量:4
  • 8Liotta L A, Steeg P S, Stetler-Stevenson W G. Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation [ J]. Cell, 1991,64(2) :327-336.
  • 9Mazar A P. Urokinase plasminogen activator receptor choreographs multiple ligund interactions: implications for tumor progression and therapy[ J]. Clin Cancer Res ,2008,14 ( 18 ) :5649-5655.
  • 10Henie E, Sixt M, Hansson S, et al. EGF-stimnlated migration in ovarion cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the uroki- nase plasminogen activator receptor [ J ]. Gynecol 0ncol,2006,101 (1) :28-39.

二级参考文献51

  • 1祝淑钗,李任,李娟,邱嵘,韩春,万钧.非手术治疗胸段食管癌临床分期与预后关系的初步探讨[J].中华放射肿瘤学杂志,2004,13(3):189-192. 被引量:70
  • 2Astedt B,Holmberg L.Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture[J].Nature,1976,261(5561):595-597.
  • 3Schmitt M,Harbeck N,Thomssen C,et al.Clinical impact of the plasminogen activation and target for therapy[J].Thromb Haemost,1997,78(1):285-296.
  • 4Look M,van Puwwen W,Duffy M,et al.Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients[J].Thromb Haemost,2003,90(3):538-548.
  • 5Okusa Y,Ichikura T,Mochizuki H.Prognostic impact of stromal Cell-derived urokinase-type plasminogen activator in gastric carcinoma[J].Cancer,1999,85(5):1033-1038.
  • 6Iseki K,Tat suata M,Uehara H,et al.Inhibitor of angiogenesis as a mechanism for inhibitor by 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymet hane in Wistar rat[J].Int Cancer,1999,81(5):730-733.
  • 7Schmalfeldt B,Kuhn W,Reuning U,et al.Primary tumor and metastasis in ovarian cancer differ in their content of urokinasetype plasminogen activator,its receptor,and inhibitors typesⅠand Ⅱ[J].Cancer Res,1995,55(21):3958-3963.
  • 8Salvi A,Bongarzone I,Micciche F,et al.Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells[J].Neoplasia,2009,11(2):207-219.
  • 9Altenberg B,Greulich KO.Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes[J].Genomics,2004,84(6):1014-1020.
  • 10Wang B,Feng P,Xiao Z,et al.LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma[J].J Hepatol,2009,50(3):528-537.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部